Ocugen Announces Submission of Emergency Use Authorization Request to the US FDA for Investigational COVID-19 Vaccine COVAXIN (BBV152) for Children Ages 2-18 Years Read more
Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab in Acute Ischemic Stroke Read more
FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure Read more
Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology Read more
Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics Read more
Dunad Therapeutics enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies Read more
Venatorx Pharmaceuticals Announces Collaboration with Roche to Develop New Class of Antibiotics targeting WHO Critical Priority Pathogen Read more
Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Drug Apabetalone Read more